Award,contract
Find a Tender
Complete
Save tender
NHS National Branded Interim - 1 June 2026
Buyer: NHS England
Deadline
Not available — this notice may describe a possible future opportunity.
Region
Not specified
Value
£529,090,780
Type
Award,contract
SME fit
—
Duration
—
Description
Provision of an NHS National Branded Interim - 1 June 2026 01/06/2026 - 30/04/2028 23 Months with an option or options to extend at the discretion of the authority up to a maximum of 25 months
Awarded to
Aspire Pharma Limited
£529,090,780
NOVARTIS PHARMACEUTICALS UK LIMITED
£529,090,780
SYNCHRONY (CNX THERAPEUTICS LIMITED)
£529,090,780
ACCORD-UK LTD
£529,090,780
ASTRAZENECA UK LIMITED
£529,090,780
AVENTIS PHARMA LIMITED
£529,090,780
CAMURUS AB
£529,090,780
CIPLA (EU) LIMITED
£529,090,780
CONSILIENT HEALTH (UK) LIMITED
£529,090,780
CST PHARMA LIMITED
£529,090,780
DAY LEWIS MEDICAL LIMITED
£529,090,780
ESSENTIAL PHARMA LIMITED
£529,090,780
Esteve Pharmaceuticals Ltd
£529,090,780
EUMEDICA PHARMA LTD
£529,090,780
FLEXIPHARM AUSTRADING LIMITED
£529,090,780
FLYNN PHARMA LIMITED
£529,090,780
GLENMARK PHARMACEUTICALS EUROPE LIMITED
£529,090,780
GRUNENTHAL LIMITED
£529,090,780
JANSSEN-CILAG LIMITED
£529,090,780
LOGIXX PHARMA LIMITED
£529,090,780
Lupin Healthcare (UK) Limited
£529,090,780
MARTINDALE PHARMA (MACARTHYS LABORATORIES LIMITED)
£529,090,780
MEDAC PHARMA LLP
£529,090,780
MERCK SHARP & DOHME (UK) LIMITED
£529,090,780
Mercury Pharmaceuticals Limited
£529,090,780
Morningside Pharmaceuticals Limited
£529,090,780
MSN Laboratories Europe Limited
£529,090,780
NAPP PHARMACEUTICALS LIMITED
£529,090,780
NEURAXPHARM UK LIMITED
£529,090,780
NORGINE PHARMACEUTICALS LIMITED
£529,090,780
ORPHALAN UK LTD
£529,090,780
PFIZER LIMITED
£529,090,780
RENASCIENCE PHARMA LIMITED
£529,090,780
Rosemont Pharmaceuticals Limited
£529,090,780
SANTEN UK LIMITED
£529,090,780
SELECTIVE SUPPLIES LIMITED
£529,090,780
SERB LTD
£529,090,780
SWEDISH ORPHAN BIOVITRUM LTD
£529,090,780
STIRLING ANGLIAN PHARMACEUTICALS LIMITED
£529,090,780
VIATRIS UK HEALTHCARE LIMITED (MYLAN)
£529,090,780
SYRI LIMITED
£529,090,780
Takeda UK Limited
£529,090,780
Teva UK Limited
£529,090,780
THEA PHARMACEUTICALS LIMITED
£529,090,780
THORNTON & ROSS LIMITED
£529,090,780
UNICORN PHARMACEUTICALS LIMITED
£529,090,780
ZENTIVA PHARMA UK LIMITED
£529,090,780
Zydus Pharmaceuticals UK Ltd
£529,090,780
ASCEND LABORATORIES (UK) LIMITED
£529,090,780
NORDIC PHARMA LIMITED
£529,090,780
SUN PHARMA UK LIMITED
£529,090,780
Quick actions
Key details
- CPV category
- —
- Procurement method
- Open procedure
- Published
- 16 Apr 2026 16:01
- VCSE suitable
- —
Reference
- OCID
- ocds-h6vhtk-05fbbc
- Notice ID
- C409236
- In our database since
- 17 Aug 2026